Fig. 1 | Signal Transduction and Targeted Therapy

Fig. 1

From: Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies

Fig. 1

Key milestones in the development of extracellular vesicle (EV)-based drugs. The figure displays a chronological timeline highlighting significant milestones or events in EV drug development from 1946 to 2023. Each marked year represents a pivotal development. (IND investigational new drug, ARDS acute respiratory distress syndrome, RMAT regenerative medicine advanced therapy)

Back to article page